The Food and Drug Administration (FDA)-approved iron supplement ferumoxytol, which contains iron oxide nanoparticles, can suppress growth of early mammary cancers and lung cancer metastasis by inducing pro-inflammatory M1 type macrophage polarization in the tumour tissue, offering a new ‘off label’ application for an approved drug.
- Saeid Zanganeh
- Gregor Hutter
- Heike Elisabeth Daldrup-Link
